Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
2.550
-0.030 (-1.16%)
At close: Nov 22, 2024, 4:00 PM
2.630
+0.080 (3.14%)
After-hours: Nov 22, 2024, 6:10 PM EST
Leap Therapeutics Employees
Leap Therapeutics had 54 employees as of December 31, 2023. The number of employees increased by 10 or 22.73% compared to the previous year.
Employees
54
Change (1Y)
10
Growth (1Y)
22.73%
Revenue / Employee
n/a
Profits / Employee
-$1,200,426
Market Cap
97.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Harvard Bioscience | 416 |
Karyopharm Therapeutics | 325 |
PetMed Express | 287 |
Adagene | 174 |
Fractyl Health | 102 |
Immunic | 77 |
MediciNova | 13 |
Tiziana Life Sciences | 9 |
LPTX News
- 9 days ago - Leap Therapeutics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 7 weeks ago - Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients - PRNewsWire
- 3 months ago - Leap Therapeutics Reports Second Quarter 2024 Financial Results - PRNewsWire
- 6 months ago - Leap Therapeutics Reports First Quarter 2024 Financial Results - PRNewsWire
- 8 months ago - Leap Therapeutics Announces $40 Million Private Placement - PRNewsWire
- 8 months ago - Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 11 months ago - Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium - PRNewsWire
- 11 months ago - Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire